Cargando…
Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant–infected patients in Jiangsu, China
BACKGROUND: The SARS-CoV-2 B.1.617.2 (Delta) variant has caused a new surge in the number of COVID-19 cases. The effectiveness of inactivated vaccines against this variant is not fully understood. METHODS: Using data from a recent large-scale outbreak of B.1.617.2 SARS-CoV-2 infection in Jiangsu, Ch...
Autores principales: | Hu, Zhiliang, Tao, Bilin, Li, Zhongqi, Song, Yan, Yi, Changhua, Li, Junwei, Zhu, Meng, Yi, Yongxiang, Huang, Peng, Wang, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769614/ https://www.ncbi.nlm.nih.gov/pubmed/35065255 http://dx.doi.org/10.1016/j.ijid.2022.01.030 |
Ejemplares similares
-
Impact of inactivated COVID-19 vaccines on viral shedding in B.1.617.2 (Delta) variant-infected patients
por: Hu, Zhiliang, et al.
Publicado: (2022) -
Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients
por: Lai, Miao, et al.
Publicado: (2023) -
Analysis of the Delta Variant B.1.617.2 COVID-19
por: Shiehzadegan, Shayan, et al.
Publicado: (2021) -
Clinical features and high-resolution chest computerized tomography findings of children infected by the B.1.617.2 variant of coronavirus disease 2019
por: Xu, Chuanjun, et al.
Publicado: (2022) -
Implication of the emergence of the delta (B.1.617.2) variants on vaccine effectiveness
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022)